STRYKER CORP (SYK) Shareholder Equity
- 2026-06-30: Additional Paid in Capital, Common StockUSD $2.71B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-576.00M; Retained Earnings (Accumulated Deficit)USD $21.82B; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $23.99B.
- 2026-03-31: Additional Paid in Capital, Common StockUSD $2.65B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-583.00M; Retained Earnings (Accumulated Deficit)USD $20.88B; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $22.98B.
- 2025-12-31: Additional Paid in Capital, Common StockUSD $2.60B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-687.00M; Retained Earnings (Accumulated Deficit)USD $20.47B; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $22.42B.
- 2025-09-30: Additional Paid in Capital, Common StockUSD $2.55B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-766.00M; Retained Earnings (Accumulated Deficit)USD $19.96B; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $21.79B.
STRYKER CORP Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Common Stock, Value, Outstanding USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.71B | $-576.00M | $21.82B | $23.99B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $2.65B | $-583.00M | $20.88B | $22.98B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $2.60B | $-687.00M | $20.47B | $22.42B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $2.55B | $-766.00M | $19.96B | $21.79B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $2.49B | $-762.00M | $19.42B | $21.19B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $2.44B | $-409.00M | $18.86B | $20.93B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $2.36B | $-293.00M | $18.53B | $20.63B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $2.35B | $-545.00M | $18.30B | $20.15B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $2.31B | $-355.00M | $17.77B | $19.76B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $2.26B | $-377.00M | $17.25B | $19.17B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $2.20B | $-416.00M | $16.77B | $18.59B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $2.18B | $-249.00M | $15.93B | $17.91B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $2.13B | $-330.00M | $15.53B | $17.36B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $2.09B | $-305.00M | $15.07B | $16.89B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $2.03B | $-221.00M | $14.77B | $16.62B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $2.03B | $-89.00M | $14.49B | $16.46B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $1.99B | $-286.00M | $13.93B | $15.67B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $1.95B | $-479.00M | $13.54B | $15.05B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $1.89B | $-531.00M | $13.48B | $14.88B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $1.88B | $-816.00M | $13.08B | $14.18B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $1.84B | $-943.00M | $12.88B | $13.82B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $1.81B | $-867.00M | $12.53B | $13.50B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.74B | $-1.16B | $12.46B | $13.08B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $1.74B | $-917.00M | $12.13B | $12.99B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $1.71B | $-715.00M | $11.72B | $12.75B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $1.68B | $-623.00M | $12.02B | $13.12B | $38.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $1.63B | $-606.00M | $11.75B | $12.81B | $37.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $1.59B | $-553.00M | $11.24B | $12.31B | $37.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $1.57B | $-630.00M | $10.97B | $11.94B | $37.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $1.54B | $-565.00M | $10.68B | $11.69B | $37.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $1.56B | $-631.00M | $10.77B | $11.73B | $37.00M | (m) | (m) | (m) | $11.73B | (m) | (m) | (m) |
| 2018-09-30 | $1.53B | $-604.00M | $8.89B | $9.86B | $37.00M | (m) | (m) | (m) | $9.86B | (m) | (m) | (m) |
| 2018-06-30 | $1.50B | $-557.00M | $8.48B | $9.46B | $37.00M | (m) | (m) | (m) | $9.46B | (m) | (m) | (m) |
| 2018-03-31 | $1.49B | $-510.00M | $8.20B | $9.22B | $37.00M | (m) | (m) | (m) | $9.21B | (m) | (m) | (m) |
| 2017-12-31 | $1.50B | $-553.00M | $8.99B | $9.98B | $37.00M | (m) | (m) | (m) | $9.97B | (m) | (m) | (m) |
| 2017-09-30 | $1.48B | $-498.00M | $9.41B | (m) | $37.00M | (m) | (m) | (m) | $10.43B | 9 month · $85.00M | (m) | (m) |
| 2017-06-30 | $1.45B | $-590.00M | $9.14B | (m) | $37.00M | (m) | (m) | (m) | $10.04B | 6 month · $58.00M | (m) | (m) |
| 2017-03-31 | $1.44B | $-675.00M | $8.90B | (m) | $37.00M | (m) | (m) | (m) | $9.70B | 3 month · $32.00M | (m) | (m) |
| 2016-12-31 | $1.43B | $-761.00M | $8.84B | $9.55B | $37.00M | (m) | (m) | (m) | $9.55B | 12 month · $97.00M | (m) | 12 month · $36.00M |
| 2016-09-30 | $1.40B | $-600.00M | $8.49B | (m) | $37.00M | (m) | (m) | (m) | $9.33B | 9 month · $71.00M | (m) | 9 month · $31.00M |
| 2016-06-30 | $1.38B | $-595.00M | $8.28B | (m) | $37.00M | (m) | (m) | (m) | $9.10B | 6 month · $49.00M | (m) | 3 month · $28.00M |
| 2016-03-31 | $1.35B | $-622.00M | $8.04B | (m) | $37.00M | (m) | (m) | (m) | $8.81B | 3 month · $28.00M | (m) | 3 month · $16.00M |
| 2015-12-31 | $1.32B | $-639.00M | $7.79B | $8.51B | $37.00M | (m) | (m) | (m) | $8.51B | 12 month · $86.00M | (m) | 12 month · $26.00M |
| 2015-09-30 | $1.32B | $-529.00M | $7.66B | (m) | $38.00M | (m) | (m) | (m) | $8.48B | 9 month · $65.00M | 3 month · $-2.00M 9 month · $-8.00M | 9 month · $23.00M |
| 2015-06-30 | $1.30B | $-431.00M | $7.60B | (m) | $38.00M | (m) | (m) | (m) | $8.51B | 6 month · $44.00M | 3 month · $-3.00M 6 month · $-4.00M | 6 month · $46.00M |
| 2015-03-31 | $1.28B | $-521.00M | $7.53B | (m) | $38.00M | (m) | (m) | (m) | $8.32B | 3 month · $23.00M | 3 month · $-1.00M | 3 month · $37.00M |
| 2014-12-31 | $1.25B | $-254.00M | $7.56B | (m) | $38.00M | (m) | (m) | $9.00M | $8.60B | 12 month · $77.00M | (m) | 12 month · $21.00M |
| 2014-09-30 | $1.23B | $-74.00M | $7.43B | (m) | $38.00M | (m) | (m) | (m) | $8.62B | 9 month · $58.00M | 3 month · $-3.00M 9 month · $-9.00M | 9 month · $6.00M |
| 2014-06-30 | $1.21B | $231.00M | $7.53B | (m) | $38.00M | (m) | (m) | (m) | $9.00B | 6 month · $41.00M | 3 month · $-3.00M 6 month · $-3.00M | 6 month · $5.00M |
| 2014-03-31 | $1.19B | $268.00M | $7.57B | (m) | $38.00M | (m) | (m) | (m) | $9.06B | 3 month · $21.00M | 3 month · $-1.00M | 3 month · $2.00M |
| 2013-12-31 | $1.16B | $232.00M | $7.62B | (m) | $38.00M | (m) | (m) | $-4.00M | $9.05B | 12 month · $76.00M | 12 month · $21.00M | 12 month · $6.00M |
| 2013-09-30 | $1.14B | $146.00M | $7.41B | (m) | $38.00M | (m) | (m) | (m) | $8.74B | 9 month · $57.00M | 3 month · $5.00M 9 month · $10.00M | 9 month · $5.00M |
| 2013-06-30 | $1.12B | $31.00M | $7.41B | (m) | $38.00M | (m) | (m) | (m) | $8.60B | 6 month · $38.00M | (m) | 6 month · $4.00M |
| 2013-03-31 | $1.10B | $17.00M | $7.30B | (m) | $38.00M | (m) | (m) | (m) | $8.46B | 3 month · $20.00M | 3 month · $1.00M | 3 month · $3.00M |
| 2012-12-31 | $1.10B | $129.00M | $7.33B | (m) | $38.00M | $226.00M | $4.00M | $-101.00M | $8.60B | 12 month · $75.00M | 12 month · $35.00M | 12 month · $1.00M |
| 2012-09-30 | $1.08B | $78.00M | $7.16B | (m) | $38.00M | (m) | (m) | (m) | $8.36B | 9 month · $57.00M | (m) | 9 month · $2.00M |
| 2012-06-30 | $1.07B | $-60.00M | $6.91B | (m) | $38.00M | (m) | (m) | (m) | $7.95B | 6 month · $39.00M | (m) | 6 month · $3.00M |
| 2012-03-31 | $1.05B | $235.00M | $6.70B | (m) | $38.00M | (m) | (m) | (m) | $8.02B | 3 month · $21.00M | (m) | 3 month · $3.00M |
| 2011-12-31 | $1.02B | $144.00M | $6.48B | (m) | $38.00M | $176.00M | (m) | $-32.00M | $7.68B | 12 month · $75.00M | (m) | 12 month · $6.00M |
| 2011-09-30 | $1.01B | $272.00M | $6.24B | (m) | $38.00M | (m) | (m) | (m) | $7.56B | 9 month · $58.00M | (m) | 9 month · $6.00M |
| 2011-06-30 | $1.00B | $484.30M | $6.25B | (m) | $38.80M | (m) | (m) | (m) | $7.78B | 6 month · $38.70M | (m) | 6 month · $4.80M |
| 2011-03-31 | $982.50M | $416.30M | $6.01B | (m) | $38.80M | (m) | (m) | (m) | $7.45B | 3 month · $19.60M | (m) | 3 month · $3.30M |
| 2010-12-31 | $964.00M | $154.00M | $6.02B | (m) | $39.00M | $196.00M | $2.00M | $-44.00M | $7.17B | 12 month · $69.00M | (m) | 12 month · $11.00M |
| 2010-09-30 | $965.30M | $209.80M | $6.09B | (m) | $39.70M | (m) | (m) | (m) | $7.31B | 9 month · $53.60M | (m) | 9 month · $10.90M |
| 2010-06-30 | $944.50M | $-51.80M | $5.81B | (m) | $39.70M | (m) | (m) | (m) | $6.75B | 6 month · $36.10M | (m) | 6 month · $10.90M |
| 2010-03-31 | $925.40M | $152.00M | $5.55B | (m) | $39.70M | (m) | (m) | (m) | $6.67B | 3 month · $18.80M | (m) | 3 month · $9.00M |
| 2009-12-31 | $899.90M | $258.00M | $5.40B | (m) | $39.80M | $277.00M | $4.00M | $-23.00M | $6.60B | 12 month · $62.00M | (m) | 12 month · $7.00 |
| 2009-09-30 | $883.60M | $326.60M | $5.19B | (m) | $39.80M | (m) | (m) | (m) | $6.44B | 9 month · $47.00M | (m) | 9 month · $5.00M |
| 2009-06-30 | $866.90M | $189.00M | $4.96B | (m) | $39.70M | (m) | (m) | (m) | $6.06B | 6 month · $31.70M | (m) | 6 month · $4.20M |
| 2008-12-31 | $812.80M | $164.80M | $4.39B | (m) | $39.60M | $203.70M | $900.00K | $-39.80M | $5.41B | 12 month · $65.50M | (m) | 12 month · $33.70M |
| 2007-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.38B | 12 month · $62.40M | (m) | 12 month · $43.50M |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.19B | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |